Teva Pharmaceutical Industries Ltd. revealed a new commercial structure June 2 in line with CEO Erez Vigodman’s promise to investors to strengthen the company’s position in generic drugs. The reorganization will establish a new Global Generic Medicines group to be led by former Actavis Pharma President Sigurdur Olafsson.
Effective July 1, the new GGM unit will consolidate all of Teva’s regional generic businesses under one group and be...